Transfection of COS-1 cells with DT-diaphorase cDNA: Role of a base change at position 609

British Journal of Cancer

Volumn 77, Issue 8, 1998, Pages 1236-1240

  Misra, V ^a,b   Klamut, H J ^a   Rauth, A M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

COS 1 cells; DT diaphorase; Polymorphism; Transfection

Indexed keywords

COMPLEMENTARY DNA; FLAVOPROTEIN; HUMAN GROWTH HORMONE; PROLINE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SERINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL LYSATE; CELL STRAIN COS1; CONTROLLED STUDY; DEFENSE MECHANISM; DNA TRANSFECTION; ENZYME ACTIVITY; EXPRESSION VECTOR; HOMOZYGOSITY; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STABILITY;

EID: 0031935057     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.208     Document Type: Article

References (34)

1. Begleiter A, Robotham E and Leith MK (1992) Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Mol Pharm 41: 677-682
2. Benson AM, Hunkler MJ and Talalay P (1980) Increase NAD(P)H:quinone reductase by dietary antioxidants. Possible role in protection against carcinogenesis and toxicity. Biochemistry 77: 5216-5220
3. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
4. Burnette WN (1981) 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112: 195-203
5. Chesis PL, Levin DE, Smith MT, Ernster L and Ames BN (1984) Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc Natl Acad Sci USA 81: 1696-1700
6. Eickelmann P, Schulz WA, Rohde B, Schitz-Drager B and Sies H (1994) Loss of heterozygosity at the NAD(P)H:quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder cell line. Biol Chem Hoppe-Seyler 375: 439-445
7. Ernster L (1967) DT-diaphorase. Methods Enzymol 10: 309-317
8. Fitzsimmons SA, Workman P, Grever M, Paull K, Camalier R and Lewis AD (1996) Reductase expression across the National Cancer Institute tumor cell line panel: correlation with sensitivity to mitomycin C and E09. J Natl Cancer Inst 88: 259-269
9. Horie S (1990) Advances in research on DT-diaphorase. Kitasato Arch Exp Med 63: 11-30
10. Hu LT, Stamberg J and Pan SS (1996) The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C. Cancer Res 56: 5223-5259
11. Iyenagi T (1987) On the mechanism of one- and two-electron transfer by flavin enzymes. Chem Scr 27A: 31-36
12. Koster AS (1991) Bioreductive activation of quinones: a mixed blessing. Pharm Weekl /Sci/ 13: 123-126
13. Koudstaal J, Makkink B and Overdip SH (1975) Enzyme histochemical pattern in human tumors - II. Oxidoreductases in the carcinoma of colon and breast. Eur J Cancer 11: 111-115
14. Kuehl BK (1995) The involvement of DT-diaphorase in mitomycin C sensitivity and in a cancer-prone phenotype. PhD thesis. University of Toronto. Department of Medical Biophysics.
15. Kuehl BK, Paterson JWE, Peacock JW, Paterson MC and Rauth AM (1995). Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer 72: 555-561
16. Lind C, Hochstein P and Ernster L (1992) DT-diaphorase as a quinoine reductase: a cellular control device against semiquinone and superoxide radical formation. Arch Biochem Biophys 216: 178-185
17. Marshall RS, Paterson MC and Rauth AM (1991) DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family. Carcinogenesis 12: 1175-1180
18. Pan SS, Forrest GL, Akman SA and Hu LT (1995) NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. Cancer Res 55: 330-335
19. Powis G (1987) Metabolism and reactions of quinoid anticancer agents. Pharmacol Ther 35: 157-162
20. Rauth AM, Marshall RS and Kuehl BL (1993) Cellular approaches to bioreductive drug mechanisms. Cancer Metastas Rev 12: 153-164
21. Robertson N, Stratford IJ, Houlbrook S, Carmichael J and Adams GE (1992) The sensitivity of human tumor cells to quinone bioreductive drugs. What role for DT-diaphorase? Biochem Pharm 44: 409-412
22. Rockwell S, Sartorelli AC, Tomasz M and Kennedy KA (1993) Cellular pharmacology of quinone bioreductive alkylating agents. Cancer Metastas Rev 12: 165-176
23. Ross D, Siegel D, Beall H, Prakash AS, Mulchay TM and Gibson NW (1993) DT-diaphorase in activation and detoxification of quinones. Cancer Metastas Rev 12: 83-101
24. Rosvold EA, McGlynn KA, Lustbader ED, Buetow RH (1995) Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 5: 199-206
25. Rothman N, Traver RD, Smith MT, Hayes RB, Li G-L, Campleman S, Dosemeci M, Zhang L, Linet M, Wacholder S, Yin S-N and Ross D (1996) Lack of NAD(P)H:quinone oxidoreductase activity (NQO1) is associated with increased benzene hematotoxicity. Proc Am Assoc Can Res 37: 258
26. Schlager JJ and Powis G (1990) Cytosolic NAD(P)H:(quinone acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 45: 403-409
27. Seldon RF, Howie KB, Rowe ME, Goodman HM and Moore DD (1996). Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol Cell Biol 9: 3173-3179
28. Siegel D, Gibson NW, Preusch, PC and Ross D (1990) Metabolism of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50: 7293-7300
29. Traver RD, Horikoshi T, Danenberg K, Stadlbauer THW, Danenberg PV, Ross D and Gibson NW (1992) NAD(P)H:quinone acceptor oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin C sensitivity. Cancer Res 52: 797-802
30. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA and Gibson NW (1997) Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase). Br J Cancer 75: 69-75
31. Verwiej J, Aamdal S, Schellens J, Koier I and Lund B (1994) Clinical studies with E09, a new indoloquinone bioreductive alkylating cytotoxic agent. Oncol Res 6: 519-523
32. Walton MI, Sugget N and Workman P (1992) The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins. Int J Radiat Oncol Biol Phys 22: 643-647
33. Workman P (1994) Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol Res 6: 461-475
34. Wu K, Deng PS-K and Chen S (1997) Catalytic properties of a naturally occurring mutant of human NAD(P)H: quinone acceptor oxidoreductase (DT-diaphorase). Pro 187 to Ser. In Pathophysiology of Lipid Peroxidases and Related Free Radicals, Yagi K (ed.). Japan Scientific Societies Press: Tokyo